demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 hospitalized
COVID-19 severe or critically
neutralizing antibody
equine polyclonal antibodies INM005 Lopardo

5 studies excluded by filtering options 1

6708 Webb, 2021 0130selection pending
6920 Rainwater-Lovett, 2021 0130selection pending
6921 Bariola, 2021 1130not a RCTrisk of bias not avaialble
9866 Jurdi, 2022 1110not a RCTrisk of bias not avaialble
10191 Chen, 2022 0100selection pending